{
  "id": 16439089,
  "title": "Got $1,000? This Nuclear Fuel Stock Is the Pick-and-Shovel Play I'd Buy Right Now.",
  "url": "https://urgent.news/2026/10/25/got-1-000-this-nuclear-fuel-stock-is-the-pick-and-shovel-play-id-buy",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-25T06:05:00.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/investing/2026/10/25/got-1000-this-nuclear-fuel-stock-is-the-pick-and-s/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": "The nuclear energy sector has experienced a decline this year, with the Global X Uranium ETF down around 15%. This trend has made it difficult for newer companies to achieve profitability, leading many to overlook the potential of pick-and-shovel nuclear stocks. One such stock is Centrus Energy (LEU -1.63%), which is the only publicly traded proven U.S. uranium enricher. Despite a 52% decrease in share price this year, Centrus remains a favorable investment opportunity, with improved valuation at approximately 33 times forward earnings.\n\nCentrus operates the sole U.S. Nuclear Regulatory Commission (NRC)-licensed facility capable of producing high-assay low-enriched uranium (HALEU), a crucial fuel for next-generation advanced small modular reactors (SMRs) and microreactors. In July, the company secured a $900 million order to produce HALEU for the U.S. Department of Energy (DOE). These multi-year supply agreements with emerging reactor developers like X-energy, Radiant Industries, and Antares Nuclear provide Centrus with a central role in the future nuclear tech boom.\n\nIn the second quarter, Centrus reported $176.1 million in revenue, a 13.9% increase compared to the same period last year. The company anticipates full-year revenue between $450 million and $500 million, up from $448.7 million in 2025. Centrus boasts a $4.5 billion backlog, with work scheduled out to 2040, highlighting long-term, fixed orders. Over $3.7 billion of this total arises from its primary fuel business, which includes selling standard reactor fuel and uranium to power utilities.\n\nThe U.S. lacks a domestic source of enriched uranium for national security and defense needs due to the closure of the Paducah, Kentucky, plant in 2013 and the dependency on Cold War-era stockpiles. Centrus leverages its proprietary AC100M centrifuge, the only American-developed, deployment-ready uranium enrichment system that complies with U.S. legal and national security requirements. This unique advantage, combined with a growing backlog, positions Centrus as a solid buy, showing promising growth and profitability compared to other AI stocks. The stock's recent decline is likely due to sector concerns rather than its financial strength.",
  "summary": "Centrus Energy is the lone publicly traded U.S.-based uranium enricher.",
  "key_points": [
    "Centrus Energy is the only U.S. uranium enricher with NRC license.",
    "Secured $900M contract for HALEU production, supporting SMRs.",
    "Reports 13.9% YoY revenue growth to $176.1M in Q2."
  ],
  "editors_take": "Centrus Energy’s unique ability to produce domestic HALEU positions the company as a critical infrastructure provider for the next generation of advanced small modular reactors and national security needs.",
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "Got $1,000? This Nuclear Fuel Stock Is the Pick-and-Shovel Play I'd Buy Right Now.",
        "url": "https://urgent.news/2026/10/25/got-1-000-this-nuclear-fuel-stock-is-the-pick-and-shovel-play-id-buy-16446655",
        "published": "2026-10-25T06:25:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}